正念项目在非临床环境中促进成人心理健康:随机对照试验的系统综述与荟萃分析
该系统综述与荟萃分析纳入136项随机对照试验共11605名非临床环境成人,评估正念项目(MBPs)对焦虑、抑郁、痛苦和幸福感的效果。与不干预相比,MBPs在多数情景下改善上述结局,但与特异性主动对照相比无显著优势,证据质量中至极低。
要点
- 与不干预相比,MBPs可中等程度改善焦虑、抑郁、痛苦和幸福感。
- 与特异性主动对照相比,MBPs无统计学显著优势。
- 证据质量中至极低,效果异质性大,不能推广至所有情景。
核心结论
- 与不干预相比,纳入研究的MBPs在非临床环境中促进心理健康,但异质性大,不支持效果可推广至所有情景。
- MBPs可能对某些常见心理健康症状有特定效果,但其他预防干预可能同样有效。
研究设计与样本
- 遵循PROSPERO CRD42018105213预注册方案,检索13个数据库至2020年8月,纳入136项随机对照试验共11605名参与者(29个国家,77%女性,年龄18至73岁)。
- 两名研究者独立筛选、提取并使用Cochrane偏倚风险工具2.0评估试验。
主要发现
- 与不干预相比,MBPs改善焦虑(8项试验;SMD=-0.56;95%CI -0.80至-0.33;p<0.001;95%PI -1.19至0.06)。
- 与不干预相比,MBPs改善抑郁(14项试验;SMD=-0.53;95%CI -0.72至-0.34;p<0.001;95%PI -1.14至0.07)。
- 与不干预相比,MBPs改善痛苦(27项试验;SMD=-0.45;95%CI -0.58至-0.31;p<0.001;95%PI -1.04至0.14)。
- 与不干预相比,MBPs改善幸福感(9项试验;SMD=0.33;95%CI 0.11至0.54;p=0.003;95%PI -0.29至0.94)。
- 与无特异性主动对照相比,MBPs改善抑郁(6项试验;SMD=-0.46;95%CI -0.81至-0.10;p=0.012;95%PI -1.57至0.66),对焦虑或痛苦无统计学显著证据。
关键数值与推荐
- 主要结局为项目完成后1至6个月经心理测量学验证的焦虑、抑郁、心理痛苦和心理健康问卷。
- 多重检验采用p<0.0125(Bonferroni)作为统计学显著性阈值。
- 与特异性主动对照相比,无统计学显著证据显示MBPs优势;排除高偏倚风险试验后仅痛苦效果保留。
- 美国试验报告的效果较小;针对较高风险人群的MBPs效果大于通用MBPs。
临床怎么用
- 在非临床环境中实施MBPs应伴随充分研究以确认发现并了解哪些情景最可能获益。
- 鉴于证据质量中至极低且异质性大,不应将MBPs效果推广至所有非临床情景。
局限性
- 根据GRADE方法,证据置信度为中至极低,主要因试验间不一致性和高偏倚风险。
- 研究间异质性大,限制效果推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an urgent need for mental health promotion in nonclinical settings. Mindfulness-based programmes (MBPs) are being widely implemented to reduce stress, but a comprehensive evidence synthesis is lacking. We reviewed trials to assess whether MBPs promote mental health relative to no intervention or comparator interventions. METHODS AND FINDINGS: Following a detailed preregistered protocol (PROSPERO CRD42018105213) developed with public and professional stakeholders, 13 databases were searched to August 2020 for randomised controlled trials (RCTs) examining in-person, expert-defined MBPs in nonclinical settings. Two researchers independently selected, extracted, and appraised trials using the Cochrane Risk-of-Bias Tool 2.0. Primary outcomes were psychometrically validated anxiety, depression, psychological distress, and mental well-being questionnaires at 1 to 6 months after programme completion. Multiple testing was performed using p < 0.0125 (Bonferroni) for statistical significance. Secondary outcomes, meta-regression and sensitivity analyses were prespecified. Pairwise random-effects multivariate meta-analyses and prediction intervals (PIs) were calculated. A total of 11,605 participants in 136 trials were included (29 countries, 77% women, age range 18 to 73 years). Compared with no intervention, in most but not all scenarios MBPs improved average anxiety (8 trials; standardised mean difference (SMD) = -0.56; 95% confidence interval (CI) -0.80 to -0.33; p-value < 0.001; 95% PI -1.19 to 0.06), depression (14 trials; SMD = -0.53; 95% CI -0.72 to -0.34; p-value < 0.001; 95% PI -1.14 to 0.07), distress (27 trials; SMD = -0.45; 95% CI -0.58 to -0.31; p-value < 0.001; 95% PI -1.04 to 0.14), and well-being (9 trials; SMD = 0.33; 95% CI 0.11 to 0.54; p-value = 0.003; 95% PI -0.29 to 0.94). Compared with nonspecific active control conditions, in most but not all scenarios MBPs improved average depression (6 trials; SMD = -0.46; 95% CI -0.81 to -0.10; p-value = 0.012, 95% PI -1.57 to 0.66), with no statistically significant evidence for improving anxiety or distress and no reliable data on well-being. Compared with specific active control conditions, there is no statistically significant evidence of MBPs' superiority. Only effects on distress remained when higher-risk trials were excluded. USA-based trials reported smaller effects. MBPs targeted at higher-risk populations had larger effects than universal MBPs. The main limitation of this review is that confidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach is moderate to very low, mainly due to inconsistency and high risk of bias in many trials. CONCLUSIONS: Compared with taking no action, MBPs of the included studies promote mental health in nonclinical settings, but given the heterogeneity between studies, the findings do not support generalisation of MBP effects across every setting. MBPs may have specific effects on some common mental health symptoms. Other preventative interventions may be equally effective. Implementation of MBPs in nonclinical settings should be partnered with thorough research to confirm findings and learn which settings are most likely to benefit.
引用
- Galante J, Friedrich C, Dawson AF, et al. Mindfulness-based programmes for mental health promotion in adults in nonclinical settings: A systematic review and meta-analysis of randomised controlled trials. PLoS Med. 2021. PMID: 33428616. doi:10.1371/journal.pmed.1003481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。